Pay in 4 interest-free payments of $6.55 Learn more
Ships within 48 hours Β· Estimated delivery Oct 19 - Oct 24
Liraglutide (Saxenda) another GLP-1 receptor agonist, recommended by NICE (TA664) for use in specialist weight management services under defined eligibility criteria, including BMI thresholds and the presence of weight-related comorbidities
The REDEFINE 2 trial examined CagriSema in adults with type 2 diabetes, a population that typically shows less weight loss with GLP-1 therapies
How does Noom Med work
It has been shown to reduce inflammation, improve insulin sensitivity, and promote the loss of fat mass
US$ 29.64
US$ 25.56
US$ 29.34
US$ 21.79
US$ 24.82
